BIO Comments On Medicare Drug Discount Agreement Announced By PhRMA, The White House And Senate Finance Committee

The following statement was issued today by the Biotechnology Industry Organization (BIO) regarding the agreement reached among the Obama administration, the Pharmaceutical Research and Manufacturers of America (PhRMA) and the Senate Finance Committee to help close the coverage gap in the Medicare prescription drug program: “We look forward to reviewing in greater detail the agreement struck among President Obama, PhRMA and the Senate Finance Committee.

More: continued here

Filed under: Medicare / Medicaid / Tricare on June 27th, 2009